Innovative health risk assessment of heavy metals in Chinese herbal medicines based on extensive data

Tian-Tian Zuo,Hong-Yu Jin,Lei Zhang,Yong-Li Liu,Jing Nie,Bi-Lian Chen,Cui-Fen Fang,Jian Xue,Xue-Yan Bi,Li Zhou,Ming-Rui Shen,Shang-Mei Shi,Shuang-Cheng Ma,Bi-lian Chen,Cui-fen Fang,Xue-yan Bi,Ming-rui Shen,Shang-mei Shi

DOI: https://doi.org/10.1016/j.phrs.2020.104987

IF: 10.334

2020-09-01

Pharmacological Research

Abstract:<p>In the present study, the concentrations of lead (Pb), cadmium (Cd), arsenic (As), mercury (Hg), and copper (Cu) in 2245 batches of Chinese herbal medicines (CHMs) were measured using inductively coupled plasma-mass spectroscopy (ICP-MS). We developed a risk assessment strategy that assessed the heavy metal-associated health risk of CHMs based on our large dataset. Using a combination of the mean and 95th percentile (P95) values of the chronic daily intake (CDI), hazard quotient (HQ), hazard index (HI), and lifetime cancer risk (CR), the health risks of the average exposure population and the high exposure population were estimated, respectively. To obtain a precise and realistic risk assessment, the exposure frequency and exposure duration were determined using questionnaire data from 20,917 randomly selected volunteers. Additionally, given the specific ingestion characteristics of CHMs, the safety factor and the transfer rates of heavy metals were highlighted as well. The concentrations of Pb, Cd, As, Hg, and Cu in 2245 batches of CHMs were 1.566, 0.299, 0.391, 0.074, and 8.386 mg/kg, respectively. The mean HI values indicated that consumption of most CHMs would not pose an unacceptable health risk to the average exposure population, except for argy wormwood leaf (1.326), morinda root (2.095), plantain herb (1.540), chrysanthemum flower (1.146), and Indian madder root (2.826). In addition, CR assessment for Pb and As revealed that, for the average exposure population, the risk of developing cancers was lower than the acceptable levels (1 × 10⁻⁴) in the clinic. However, the P95 of the HI and CR values indicated that more attention should be paid to the systemic effects of CHMs in terms of both non-carcinogenic and carcinogenic health risks for the high exposure population. Furthermore, in order to serve population health better, national and international guidelines have now been established. The risk assessment strategy developed in this study is the first of its kind, and contributed to the risk assessment, guidelines, and safety standards for heavy metals in CHMs.</p>

pharmacology & pharmacy

What problem does this paper attempt to address?

The problem this paper attempts to address is: evaluating the health risks of heavy metals in Chinese herbal medicine. Specifically, the researchers measured the concentrations of lead (Pb), cadmium (Cd), arsenic (As), mercury (Hg), and copper (Cu) in 2245 batches of herbal medicine and developed a health risk assessment strategy based on a large amount of data to scientifically assess the non-carcinogenic and lifetime cancer risks of these heavy metals to human health.

The main objectives of the study include:
1. Monitoring the content of Pb, Cd, As, Hg, and Cu in herbal medicine.
2. Developing an effective risk assessment method for herbal medicine to scientifically evaluate the non-carcinogenic and lifetime cancer risks of these heavy metals to human health.
3. Establishing guidelines for heavy metal safety standards applicable to herbal medicine, improving the standardization level of herbal medicine, and ensuring the safety of clinical use.

Through this study, the authors hope to fill the current research gap in the field of health risk assessment of herbal medicine and provide a scientific basis for the formulation of relevant standards and guidelines.